RBI-4000

N/A

Report date: 2026/05/12 09:10:27

First In Class

Base Information

Drug NameRBI-4000

Drug Alias NameRBI-4000

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsProstatic NeoplasmsRabies

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesImmunomic Therapeutics Inc Replicate Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesInstituto Butantan Immunomic Therapeutics Inc Replicate Bioscience Inc

Inactive CompaniesN/A

Active IndicationsProstatic NeoplasmsRabies

Inactive IndicationsN/A

Other Information

ATC CodeN/A